Balyasny Asset Management
BTAI icon

Balyasny Asset Management’s BioXcel Therapeutics BTAI Stock Holding History

Balyasny Asset Management’s Portfolio BTAI Stock Details BTAI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-1,300
Closed -$52.6K – 1935
2023
Q3 		$52.6K Buy
+1,300
New +$52.6K ﹤0.01% 1675